Авторы заявляют об отсутствии конфликта инте- ресов. ЛИТЕРАТУРА/REFERENCES 1.
Ginsberg MD. Current status of neuroprotection for cerebral ischemia:
synoptic overview.
Stroke . 2009;40(3):111-114.
https://doi.org/ 0.1161/STROKEAHA.108.528877
2. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and
future.
Neuropharmacology . 2008;55(3):363-389.
3. Labiche LA, Grotta JC. Clinical trials for cytoprotection in stroke.
NeuroRx . 2004;1(1):46-70.
4.
Majid A. Neuroprotection in stroke: past, present, and future.
ISRN Neurol .
2014;21:515716. https://doi.org/10.1155/2014/515716
5. Baron JC, Macrae IM, Adams HP Jr, Dirnagl U. ESC-BRAIN:
experimental and clinical stroke research-do they connect? Meeting report
of the ESC-BRAIN joint symposium held in London and Shanghai in May
2013.
Cerebrovasc Dis. 2013;36(4):306-321.
https://doi.org/10.1159/000355027
6. O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH,
Howells DW. 1,026 experimental treatments in acute stroke.
Ann Neurol .
2006;59(3):467-477.
7. Philip M, Benatar M, Fisher M, Savitz SI. Methodological quality of
animal studies of neuroprotective agents currently in phase II/III acute
ischemic stroke trials.
Stroke . 2009;40(2):577-581.
https://doi.org/10.1161/STROKEAHA.108.524330
8. Dirnagl U, Hakim A, Macleod M, Fisher M, Howells D, Alan SM,
Steinberg G, Planas A, Boltze J, Savitz S, Iadecola C, Meairs S. A concerted
appeal for international cooperation in preclinical stroke research.
Stroke .
2013; 44(6):1754-1760.
https://doi.org/10.1161/STROKEAHA.113.000734
9. Sena E, van der Worp HB, Howells D, Macleod M. How can we improve
the pre-clinical development of drugs for stroke?
Trends Neurosci. 2007;30(9):433-439.
10. Шмонин А.А., Байса А.Е., Мельникова Е.В., Вавилов В.Н., Власов Т.Д.
Защитные эффекты раннего ишемического прекондиционирования
при фокальной ишемии мозга у крыс: роль коллатерального крово-
обращения.
Российский физиологический журнал им. И.М. Сеченова .
2011;97(2):203-213. [Shmonin AA, Baisa AE, Melnikova EV, Vavilov VN,
Vlasov TD. Protective effects of early ischemic precondition in focal cere-
bral ischemia in rats: the role of collateral circulation.
Russian Journal of Physiology I.M. Sechenov . 2011;97(2):203-213. (In Russ.)].
11. Dirnagl U.
Rodent Models of Stroke. 2010. Publisher: Humana Press; 2010.
12. Kahle MP, Bix GJ. Successfully Climbing the «STAIRs»: Surmounting
Failed Translation of Experimental Ischemic Stroke Treatments.
Stroke Res Treat. 2012;374098. https://doi.org/10.1155/2012/374098
13. Wang MM, Xi G, Keep RF. Should the STAIR criteria be modified for
preconditioning studies?
Transl Stroke Res. 2013;4(1):3-14.
https://doi.org/10.1007/s12975-012-0219-0
14. Wang-Fischer Y.
Manual of Stroke Models in Rats. USA. NY. Publisher:
Taylor & Francis Group; 2009.
15. Chopp M, Zhang RL, Zhang ZG, Jiang Q. The clot thickens: thrombolysis
and combination therapies.
Acta Neurochir Suppl (Wien) . 1999;73:67-71.
16. Zhang RL, et al. A rat model of focal embolic cerebral ischemia.
Brain Res. 1997;766:83-92.
17. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB,
Hurn P, Liebeskind DS, Nogueira RG, Saver JL; STAIR VII Consortium.
Stroke Treatment Academic Industry Roundtable (STAIR) recom-
mendations for maximizing the use of intravenous thrombolytics and
expanding treatment options with intra-arterial and neuroprotective
therapies.
Stroke . 2011;42(9):2645-2650.
https://doi.org/10.1161/STROKEAHA.111.618850
18. Handbook: good laboratory practice (GLP): quality practices for regulated
non-clinical research and development — 2nd ed World Health Organiza-
tion on behalf of the Special Programme for Research and Training in
Tropical Diseases. Publisher: «WHO Library Cataloguing-in-Publication
Data». 2009;327.
19. Миронова А.Н. Руководство по проведению доклинических исследо-
ваний лекарственных средств. Часть 1. М.: Издательство «ГрифиК»;
2012. [Mironova AN.